BRACANAT is an Indian generic of olaparib 150 mg, manufactured by Natco Pharma. It contains the same active ingredient as the original Lynparza. It is a PARP inhibitor for targeted therapy of ovarian, breast, prostate and pancreatic cancer in patients with BRCA1/2 mutations or other DNA-repair defects.
Olaparib blocks PARP enzymes that cells use to repair damaged DNA. In BRCA-mutated tumour cells the second repair pathway is already broken, so once PARP is blocked they accumulate DNA damage and die (synthetic lethality). Healthy cells are affected much less.
Whether to use it, the dose and the length of treatment are decided by your oncologist.
The active ingredient (olaparib), strength and way of use are the same as in the original. BRACANAT is made in India by Natco Pharma under the oversight of the Indian regulator CDSCO, while Lynparza is made by AstraZeneca. The Indian generic costs several times less than the original brand.
Sacred Leaves exports BRACANAT directly from New Delhi, India, with no intermediaries. Since 2015 we have completed more than 101,000 shipments to patients, clinics, pharmacies and distributors around the world.
Delivery times depend on the destination country and its customs. Before ordering, please make sure the medicine is allowed to be imported into your country. Full details: Delivery and payment.
Bank transfer (SWIFT) or PayPal. Customers in Russia can also pay in rubles via Sber QR code. Your order is dispatched once payment is received.
Do I need a prescription for BRACANAT?
Yes. It is a prescription medicine, prescribed and monitored by your oncologist; use it only as directed. Please also check your country's rules on importing medicines for personal use before ordering.
What is the difference between BRACANAT and Lynparza?
The active ingredient and strength are the same: olaparib 150 mg. BRACANAT is made by Natco Pharma, Lynparza by AstraZeneca. The Indian generic costs several times less than the original brand.
How do I take olaparib?
Only as prescribed by your oncologist. The standard labelled tablet dose is 300 mg (two 150 mg tablets) twice daily, with or without food; 100 mg tablets are used for dose reductions. Olaparib tablets and capsules are not interchangeable milligram for milligram. Blood counts are checked monthly.
Do I need a BRCA test before taking olaparib?
Yes. Olaparib works mainly in tumours with BRCA1/2 mutations or homologous recombination deficiency (HRD), so genetic testing of the tumour or blood is done before treatment.
How long does delivery take?
By international post, usually 10–20 days; by air freight, 7–10 days. Exact timing depends on your country and its customs. You receive a tracking number once the parcel is dispatched.
Can I buy BRACANAT wholesale?
Yes. We supply distributors, pharmacies, hospitals and clinics worldwide. Use the wholesale request form on this page or message us on WhatsApp.
High-grade BRCA-positive ovarian cancer
Metastatic BRCA-mutated breast cancer
Advanced prostate cancer linked to DNA repair dysfunction
Maintenance treatment in platinum-responsive patients
Swallow the tablets whole, with or without food, as prescribed by your oncologist. Dosage and duration depend on clinical response and tolerability. Liver, kidney and blood function should be regularly monitored during therapy.
Hypersensitivity to olaparib or formulation ingredients
Pregnancy and lactation
Severe hepatic or renal impairment
Paediatric patients
History of myelodysplastic syndrome or acute myeloid leukaemia
Haematological: anaemia, neutropenia, thrombocytopenia
Gastrointestinal: nausea, vomiting, dyspepsia
General: fatigue, headache
Metabolic: increased serum creatinine
Hypersensitivity or skin reactions
Rare: interstitial lung disease









